首页> 美国卫生研究院文献>Journal of Endourology Case Reports >Getting Out of a PCCL: Percutaneous Cholecystolithotomy as a Salvage Treatment Option for Gallstone Removal in Patients Deemed Unfit for Standard Surgical Approaches
【2h】

Getting Out of a PCCL: Percutaneous Cholecystolithotomy as a Salvage Treatment Option for Gallstone Removal in Patients Deemed Unfit for Standard Surgical Approaches

机译:走出PCCL:经皮胆囊切除术作为被认为不适合标准手术方法的患者胆结石切除术的挽救性治疗选择

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Definitive management of acute cholecystitis or symptomatic cholelithiasis in exceedingly high-risk patients remains a clinical dilemma. In certain cases, treatment through a percutaneous approach following standard techniques and principles similar to those of percutaneous nephrolithotomy may be considered. However, one potential challenge, particularly among a high-risk population, is the possible necessity to stay on obligate anticoagulation for pre-existing medical reasons. To date, there have been no prior reports documenting the role of this procedure in patients on systemic anticoagulation, particularly clopidogrel. Here we report a case of a percutaneous cholecystolithotomy performed on an elderly patient unable to stop dual antiplatelet therapy (aspirin and clopidogrel) secondary to recent drug eluting stent placement for myocardial infarction.
机译:在极高风险的患者中明确治疗急性胆囊炎或有症状的胆石症仍然是临床难题。在某些情况下,可以考虑遵循与经皮肾镜取石术相似的标准技术和原理,通过经皮方法进行治疗。然而,一个潜在的挑战,特别是在高危人群中,是由于先前存在的医学原因而必须继续专心抗凝的潜在挑战。迄今为止,尚无以前的报道证明该方法在全身性抗凝尤其是氯吡格雷患者中的作用。在这里,我们报道了一名老年患者的经皮胆囊结石切除术,该患者因近期发生心肌梗死的药物洗脱支架植入而无法停止双重抗血小板治疗(阿司匹林和氯吡格雷)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号